Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Check-Cap Ltd. Ordinary Share

MBAINASDAQ
Healthcare
Medical - Diagnostics & Research
$1.74
$0.00(0.00%)
U.S. Market is Open • 14:14

Check-Cap Ltd. Ordinary Share (MBAI) Stock Forecast & Price Predictions

Get the latest Check-Cap Ltd. Ordinary Share (MBAI) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$1.86
Change↑ $0.12 (6.90%)

Quarterly Forecast

Predicted Price$3.17
Change↑ $1.43 (82.18%)

Yearly Forecast

Predicted Price$15.10
Change↑ $13.36 (767.73%)

3 Years Forecast

Predicted Price$41.82
Change↑ $40.08 (2303.55%)

5 Years Forecast

Predicted Price$68.56
Change↑ $66.82 (3839.97%)

7 Years Forecast

Predicted Price$95.37
Change↑ $93.63 (5380.99%)

Check-Cap Ltd. Ordinary Share Stock Forecast Summary

Check-Cap Ltd. Ordinary Share (MBAI) stock is currently priced at $1.74. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $1.86.

In the long term, MBAI shows a bullish trend. The 2027 forecast points to $15.10 (767.73% change), while the 2031 forecast suggests $68.56 (3839.97% change). Looking 7 years ahead, projections estimate the stock could trade near $95.37, a 5380.99% change from today’s price.

Overall Sentiment

Bullish

Short-Term Outlook

Bullish

Long-Term Outlook

Bullish

This mix indicates that Check-Cap Ltd. Ordinary Share stock is expected to rise steadily over the coming years.

Check-Cap Ltd. Ordinary Share yearly Price Forecast Chart

Explore the yearly forecast chart for MBAI, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Check-Cap Ltd. Ordinary Share over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for MBAIForecasting details for MBAI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Check-Cap Ltd. Ordinary Share Stock Forecast 2026

The forecast for Check-Cap Ltd. Ordinary Share (MBAI) in 2026 suggests a price of $15.10, representing a 767.73% move from today’s price.

Average Target: $15.10

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Check-Cap Ltd. Ordinary Share Stock Forecast 2030

By 2030, Meyka AI projects MBAI could trade near $68.56, showing a potential 3839.97% compared to current levels.

Average Target: $68.56

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Check-Cap Ltd. Ordinary Share.

Check-Cap Ltd. Ordinary Share 7-Year Stock Forecast (20322033)

Looking 7 years ahead, the long-term forecast for MBAI points to a price around $95.37, which is a projected 5380.99% move from today’s level.

Average Target: $95.37

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • Check-Cap Ltd. Ordinary Share’s ability to maintain market leadership.

Frequently Asked Questions